- P-ISSN 1010-0695
- E-ISSN 2288-3339
- 권한신청
- P-ISSN1010-0695
- E-ISSN2288-3339
논문 상세
Home > 논문 상세
Kaurenoic acid, a Diterpene Derived from Aralia continentalis, Alleviates Lipogenesis in HepG2 Cells.
대한한의학회지 / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2015, v.36 no.4, pp.73-78
(Pusan National University)
(Pusan National University)
(Pusan National University)
(Pusan National University)
(부산대학교)
(Pusan National University)
(Pusan National University)
(Pusan National University)
(부산대학교)
Yu,
G.
K.
,
Jae,
H.
K.
,
Yong,
W.
J.
,
Min,
J.
K.
,
&
한창우.
(2015). . 대한한의학회지, 36(4), 73-78.
- 다운로드 수
- 조회수
Abstract
Objectives: Here we investigated the anti-lipogenic potential of kaurenoic acid (KA), a diterpene derived from Aralia continentalis, in a cellular model of non-alcoholic fatty liver disease. Methods: HepG2 cells were treated with palmitate for 24h to induce intracellular lipid accumulation. To assess the influence of KA on steatotic HepG2 cells, various concentration of KA was co-administered. After palmitate treatment, Intracellular triglyceride content was measured. Expression level of several lipogenic genes, sterol regulatory element-binding transcription factor-1c (SREBP-1c) , acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), and stearoyl-CoA desaturase-1 (SCD-1) were measured using Western-blot analyses or RT-PCR. Results: Palmitate markedly increased intracellular triglyceride level and expression of related lipogenic genes in HepG2 cells, and which was relieved by co-administered KA. Conclusions: It is conceivable that that KA may have a pharmacological potential to reduce lipid accumulation in non-alcoholic fatty liver disease.
- keywords
- Kaurenoic acid, Aralia continentalis, Non-alcoholic fatty liver disease, HepG2 cell
참고문헌
1
1. Kanuri G, Bergheim I. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). Int J Mol Sci. 2013;14(6):11963-80.
2
2. Kneeman JM, Misdraji J, Corey KE. Secondary causes of nonalcoholic fatty liver disease. Therapeutic advances in gastroenterology. 2012;5(3):199-207.
3
3. Kim CH, Younossi ZM. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleveland Clinic journal of medicine. 2008;75(10):721-8.
4
4. Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Annals of the New York Academy of Sciences. 2013;1281:106-22.
5
5. Smith BW, Adams LA. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci. 2011;48(3):97-113.
6
6. Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, et al. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. International journal of molecular medicine. 2008;21(4):507-11.
7
7. Ferre P, Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes, obesity & metabolism. 2010;12(Suppl2):83-92.
8
8. Lim H, Jung HA, Choi JS, Kim YS, Kang SS, Kim HP. Anti-inflammatory activity of the constituents of the roots of Aralia continentalis. Archives of pharmacal research. 2009;32(9):1237-43.
9
9. Wu JN. An illustrated Chinese materia medica. Oxford University Press. 2005.
10
10. Choi RJ, Shin EM, Jung HA, Choi JS, Kim YS. Inhibitory effects of kaurenoic acid from Aralia continentalis on LPS-induced inflammatory response in RAW264.7 macrophages. Phytomedicine. 2011;18(8-9):677-82.
11
11. Lyu JH, Lee GS, Kim KH, Kim HW, Cho SI, Jeong SI, et al. ent-kaur-16-en-19-oic Acid, isolated from the roots of Aralia continentalis, induces activation of Nrf2. Journal of ethnopharmacology. 2011;137(3):1442-9.
12
12. Jeong SI, Kim BS, Keum KS, Lee KH, Kang SY, Park BI, et al. Kaurenoic Acid from Aralia continentalis Inhibits Biofilm Formation of Streptococcus mutans. Evid Based Complement Alternat Med. 2013;2013:160592.
13
13. Bryan HK, Olayanju A, Goldring CE, Park BK. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochemical pharmacology. 2013;85(6):705-17.
14
14. Bataille AM, Manautou JE. Nrf2: a potential target for new therapeutics in liver disease. Clinical pharmacology and therapeutics. 2012;92(3):340-8.
15
15. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. The Journal of clinical investigation. 2004;114(2):147-52.
- 다운로드 수
- 조회수
- 0KCI 피인용수
- 0WOS 피인용수
권호 내 다른 논문
- Effects of Embedding Therapy on Frozen Shoulder : A Prospective Study
- Antispastic Effect of Electroacupuncture on Upper Extremity in Stroke Patients by T-reflex Study: A Single-Blind, Randomized Controlled, Preliminary Study
- The Anti-tumor Effect of Orostachys japonicus Extracts on Cholangiocarcinoma Cell Line SNU-1079
- Analysis for Individual-authorization of Functional Food Materials in Korea
- Protective Effects of BK-1202 on the Indomethacin-induced Gastric Ulcer in Rats
- A Study about Quality Control of Herb Medicine Extract Granules – About DanggwiSayeuggaosuyusaenggangtang(DSGOST)
- Study on the Skin of Hand Lesser Yang from the Viewpoint of Human Anatomy
- Kaurenoic acid, a Diterpene Derived from Aralia continentalis, Alleviates Lipogenesis in HepG2 Cells.
- Trend Analysis of the Research on Bee Venom Acupuncture in South Korea, Based on Published Articles
- A case report of generalized morphea treated with herbal medication and moxibustion
- Acute Viral Hepatitis A with Cholestatic Hepatitis Treated with Traditional Korean Medicine : A Case Report
- Microneedling (transtherapy) for moderate to severe acne scar: a study of 2 cases
- A Trend Analysis of Case Reports and Case Series on Hwa-byung in Korea
- Acupuncture effect on Chemotherapy-induced Vomiting and Nausea: A case series
- A Case Report of Efficacy of Growth Height and Peak-Luteinizing Hormone Level Suppression on Idiopathic Gonadotropin-Dependent Precocious Puberty Patient Using Herbal Remedy, Aesopjiyoun-tang
- more
추천 논문
학술지 홈페이지 이용 환경은 크롬 브라우저 사용을 권장합니다.